Serum neuron-specific enolase as a marker of brain ischemia-reperfusion injury in patients undergoing carotid endarterectomy.
Key words: Carotid endarterectomy; Ischemic stroke; Neuron-specific enolase
Stroke including ischemic stroke is one of the major public health problems worldwide, particularly in industrialized countries. Strokes are a frequent cause of acute hospitalization, severe morbidity, and the third cause of overall mortality(1).
Surgical treatment of atherosclerotic stenosis of the extracranial segment of internal carotid artery is an effective method of preventing cerebral ischemic stroke(2). However, it should be noted that the procedure is burdened with the consequences of neurological complications during the perioperative period. Microembolisms, macroembolisms, and increased or decreased blood flow to the brain as a result of internal carotid artery endarterectomy (CEA) may lead to ischemic and/or hyperperfiision brain damage(3-5).
Neuron-specific enolase (NSE) is a dimeric isoenzyme of the glycolytic enzyme enolase. NSE has a molecular weight of approximately 80 kDa and is found mainly in the neurons and cells of the neuroendocrine system. It participates in slow axoplasmic transport. NSE is not normally secreted, but when axons are damaged, NSE is upregulated to maintain homeostasis. Therefore, NSE is the only marker that directly assesses functional damage to neurons. As NSE is mainly found in neurons, its level in serum or cerebrospinal fluid (CSF) may be elevated in neurological diseases. According to Jauch et al., biochemical markers of acute neuronal injury including NSE may play a role in the diagnosis and management of cerebral ischemia. The authors observed increased 24-h peak levels of NSE that were associated with higher than normal baseline scores set forth by the National Institutes of Health Stroke Scale. Moreover, serum NSE may have a prognostic value in traumatic brain injury. Unfavorable outcomes and mortality of patients were significantly associated with increased serum NSE levels. It is also concluded that NSE has a moderate discriminatory ability to predict mortality and neurological outcome in patients with traumatic brain injury(6,7).
Therefore, NSE may also be a biochemical marker of brain ischemia-reperfiision injury in patients undergoing CEA. The aim of the study was to investigate serum NSE levels and its changes over time in these patients.
Patients and Methods
The study involved patients hospitalized in the Department of Vascular Surgery and Angiology, Medical University of Lublin, Lublin, Poland, undergoing CEA due to internal carotid artery stenosis. Patients were qualified for surgical treatment according to the guidelines of the European Society of Vascular Surgery based on Doppler studies performed using a Toshiba Aplio 500 ultrasound(8). Patients with high grade stenotic carotid arteries were identified and measured by using the guidelines set by the North American Symptomatic Carotid Endarterectomy Trial (NASCET)(9).
The study group consisted of 25 participants (15 male and 10 female) aged from 54 to 88 years, average 69 years. Patients with occlusion of the internal carotid artery were not qualified for surgery and research. The degree of internal carotid artery stenosis ranged from 60% to 90%. The average clamping time of internal carotid artery during CEA was 8.5 minutes. Conventional CEA was performed under local anesthesia. Shunt was not used. No complications associated with CEA were observed. The mean velocity of blood flow in the internal carotid artery was 208.4 cm/s (blood flow 1) before surgery and 89.5 cm/s (blood flow 2) after surgery. Past medical histories of study subjects included previous ischemic stroke (n=8), transient ischemic attack (n=7), and asymptomatic internal carotid artery stenosis (n=10). The study criteria disqualified patients with known organic brain damage in the course of various diseases of the nervous system (e.g., multiple sclerosis, Alzheimer's disease).
Blood samples were obtained from each patient from the antecubital vein on three occasions: within 24 h prior to surgery (NSE 1), 12 h after surgery (NSE 2), and 48 h after surgery (NSE 3). Serum samples were collected into plastic tubes, centrifuged rapidly, and stored at -80 [degrees]C until analysis. Serum NSE levels were measured by a commercially available enzyme-linked immunosorbent assay (Enzyme-Linked Immunosorbent Assay Kit for Enolase, Neuron Specific (NSE), Cloud Clone Corp./USCN, Houston, TX, USA).
Statistical analysis was performed using STATISTICA version 10 software (StatSoft, Inc., Poland). Distribution of the collected data was evaluated using the Shapiro-Wilk's test. Furthermore, data on the NSE levels were analyzed using ANOVA with post hoc Tukey HSD test. For the dichotomous system, Student's t-test and Mann-Whitney U test (depending on the distribution obtained) were used to examine between-group differences. Correlation analysis was performed using the Spearman rank correlation. The NSE values were expressed in ng/mL. The values of p<0.05 were considered significant.
The study was approved by the Ethics Committee of Medical University in Lublin (KE-0254/218/2014).
The ANOVA test showed that sampling time significantly affected serum NSE levels (p<0.05). Serum NSE levels and comparative analysis are presented in Table 1.
The post hoc Tukey HSD test revealed that serum NSE level was statistically significantly increased 48 h after CEA as compared with the levels measured 12 h after surgery and prior to surgery (p<0.05). However, difference in serum NSE levels prior to surgery and 12 h after CEA was not statistically significant (p>0.05) (Table 2).
There was no statistically significant difference in serum NSE levels between symptomatic and asymptomatic patients (p>0.05). There was no statistically significant correlation between serum NSE levels and clamping time either (p>0.05).
There was no statistically significant correlation of serum NSE levels with blood flow velocity in internal carotid artery before CEA and after surgery (p>0.05) (Table 3).
However, change in the blood flow calculated as: [(blood flow rate after surgery--blood flow rate prior to surgery)/blood flow rate prior to surgery]*100 and change in the NSE2 and NSE3 levels indicated statistically significant correlations (r=0.45, p=0.0239; and r=0.41, p=0.0394, respectively). The correlation between NSE2/NSE3 levels and blood flow velocity in internal carotid artery is illustrated in Figure 1.
Our study revealed that serum NSE level was statistically significantly increased 48 h after CEA as compared with the levels 12 h after surgery and prior to surgery. Dragas et al.(10) observed that changes in serum NSE occurred after CEA. The authors concluded that serum NSE could be used as a potential marker of brain injury after surgery. Capoccia et al.(11) investigated the relationship between serum levels of two biochemical markers of cerebral injury, S100 protein and NSE, using postoperative diffusion-weighted magnetic resonance imaging, and neuropsychometric testing in patients undergoing CEA or carotid artery stenting (CAS). The authors observed that the aforementioned biochemical markers were significantly increased at 24 h in CAS patients as compared with CEA patients. According to the authors, the increased S100 and NSE levels following CAS may be caused by perioperative microembolization rather than hypoperfusion. Bright-well et al.(12) measured serum S-100b and NSE levels in patients undergoing CEA and CAS, and found associated hemodynamic and embolic events detected using transcranial Doppler (TCD). TCD findings showed that the mechanisms of these increased biochemical markers may have differed, and thus may have been caused by microembolization and cerebral hypoperfusion, respectively. According to the authors, cerebral hypoperfusion is responsible for the increase of the above mentioned brain damage markers in cases related to CEA.
Serum levels of NSE were measured intraoperatively, prior to and after carotid clamping. There was no difference in subtle cerebral damage between patients randomized to receive a shunt or not(13). Gao et al.(14) studied NSE levels in serum of patients before, during, and for 2 days after CEA performed under general anesthesia and incorporating the use of a Javid shunt. Serum NSE level increased during shunting, while the CSF NSE level did not change.
Different results were obtained in studies conducted by Rasmussen et al.(15). The authors measured serum levels of NSE in patients before CEA and postoperatively at 12, 24, 36 and 48 h. Compared with abdominal aortic surgery patients, the preoperative serum level of NSE was significantly higher in carotid artery surgery patients. Postoperatively, serum NSE level decreased significantly after uncomplicated CEA, and the level was then similar to that in the aortic surgery patients. The authors concluded that subtle brain damage after carotid artery surgery could not be detected by measuring blood levels of NSE.
The mechanism of serum NSE elevation observed in our study is unknown, but we support the hypothesis that increased blood-brain barrier permeability caused by hypoxia during carotid cross-clamping may influence NSE leaking from the brain into the blood. Cerebral damage during carotid clamping may be the result of microembolism and/or hypoperfusion. Elevated serum NSE levels may reflect ischemia-induced enzyme loss. An increase in serum NSE level may also be caused by hyperperfusion brain damage during CEA. In many patients, clamping of the internal carotid artery during CEA results in transient decrease in cerebral blood flow in the ipsilateral cerebral hemisphere(16). If this decrease in the hemispheric cerebral blood flow is significant enough to impair autoregulation, then consequently ipsilateral cerebral hyperperfusion can occur after internal carotid artery declamping. Development of cerebral hyperperfusion after CEA is associated with preoperative hemodynamic impairment and intraoperative cerebral ischemia(17). It has been suggested that acute ischemia and reperfusion by clamping and declamping of the internal carotid artery may produce oxygen-derived free radicals resulting in impairment of cerebrovascular autoregulation, postischemic hyperperfusion, or/and brain edema(18,19).
Brouns et al.(20) investigated CSF levels of different neuromarkers including NSE in acute ischemic stroke patients and their relation to initial stroke severity, stroke location, and long-term stroke outcome. They concluded that biomarkers displayed relevant differences in cellular and subcellular origins, which were reflected in their relation to stroke characteristics.
In conclusion, data from our study showed that CEA affected serum NSE in patients with significant internal carotid artery stenosis. Thus, serum NSE may be used as a biochemical marker of brain ischemia-reperfusion injury after CEA.
The study was funded by the Foundation for the Development of Vascular Surgery at the Department of Vascular Surgery and Angiology, Medical University of Lublin, Lublin, Poland.
(1.) Bejot Y, Benatru I, Rouaud O, Fromont A, Besancenot JP, Moreau T, et al. Epidemiology of stroke in Europe: geographic and environmental differences. J Neurol Sci. 2007;262:85-8, http://dx.doi.org/10.1016/j.jns.2007.06.025
(2.) Pyshkina LI, Khatagova DT, Kabanov AA, Darvish NA, Alibekova ZM. Surgical prevention of stroke in patients with carotid stenosis. Zh Nevrol Psikhiatr Im S S Korsakova. 2014; 114:14-9.
(3.) Gupta N, Corriere MA, Dodson TF, Chaikof EL, Beaulieu RJ, Reeves JG, et al. The incidence of microemboli to the brain is less with endarterectomy than with percutaneous revascularization with distal filters or flow reversal. J Vasc Surg. 2011;53: 316-22, http://dx.doi.org/10.1016/j.jvs.2010.08.063
(4.) Backhaus R, Boy S, Fuchs K, Ulrich B, Schuierer G, Schlachetzki F. Hyperperfusion syndrome after MCA embolectomy--a rare complication? Am J Case Rep. 2013;14:513-7, http://dx.doi.org/10.12659/AJCR.889672
(5.) Ballesteros-Pomar M, Alonso-Argueso G, Tejada-Garcia J, Vaquero-Morillo F. Cerebral hyperperfusion syndrome in carotid revascularization surgery. Rev Neurol. 2012;55(8):490-8.
(6.) Jauch EC, Lindsell C, Broderick J, Fagan SC, Tilley BC, Levine SR. Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant plasminogen activator stroke study. Stroke 2006;37:2508-13, https://doi.org/10.1161/01.STR.0000242290.01174.9e
(7.) Cheng F, Yuan Q, Yang J, Wang W, Liu H. The prognostic value of serum neuron-specific enolase in traumatic brain injury: systematic review and meta-analysis. PloS One. 2014;9(9);e106680, http://dx.doi.org/10.1371/journal.pone.0106680
(8.) Liapis CD, Bell PF, Mikhailidis DP, Sivenius J, Nicolaides A, Fernandes e Fernandes J, et al. ESVS guidelines: Invasive treatment for carotid stenosis: indications, techniques. Eur J Vasc Endovasc Surg. 2009;37(4 Suppl):1-19, http://dx.doi.org/10.1016/j.ejvs.2008.11.006
(9.) Staikov IN, Arnold M, Mattle HP, Remonda L, Sturzenegger M, Baumgartner RW, et al. Comparison of the ECST, CC, and NASCET grading methods and ultrasound for assessing carotid stenosis. European Carotid Surgery Trial. North American Symptomatic Carotid Endarterectomy Trial G. J Neurol. 2000;247(9):681-6.
(10.) Dragas M, Koncar I, Opacic D, Ilic N, Maksimovic Z, Markovic M, et al. Fluctuations of serum neuron specific enolase and protein S-100B concentrations in relation to the use of shunt during carotid endarterectomy. PLoS One. 2015;10(4): e0124067, http://dx.doi.org/10.1371/journal.pone.0124067
(11.) Capoccia L, Speziale F, Gazzetti M, Mariani P, Rizzo A, Man-sour W, et al. Comparative study on carotid revascularization (endarterectomy vs stenting) using markers of cellular brain injury, neuropsychometric tests, and diffusion-weighted magnetic resonance imaging. J Vasc Surg. 2010;51(3):584-91, http://dx.doi.org/10.1016/j.jvs.2009.10.079
(12.) Brightwell RE, Sherwood RA, Athanasiou T, Hamady M, Cheshire NJ. The neurological morbidity of carotid revascularisation: using markers of cellular brain injury to compare CEA and CAS. Eur J Vasc Endovasc Surg. 2007;34(5):552-60, http://dx.doi.org/10.1016/j.ejvs.2007.06.016
(13.) Palombo D, Lucertini G, Mambrini S, Zettin M. Subtle cerebral damage after shunting vs non shunting during carotid endarterectomy. Eur J Vasc Endovasc Surg. 2007;34(5):546-51, http://dx.doi.org/10.1016/j.ejvs.2007.05.028
(14.) Gao F, Harris DN, Sapsed-Byrne S, Standfield NJ. Nerve tissue protein S-100 and neurone-specific enolase concentrations in cerebrospinal fluid and blood during carotid endarterectomy Anaesthesia. 2000;55(8):764-9.
(15.) Rasmussen LS, Christiansen M, Johnsen J, Gronholdt ML, Moller JT. Subtle brain damage cannot be detected by measuring neuron-specific enolase and S-100beta protein after carotid endarterectomy. J Cardiothorac Vasc Anesth. 2000;14(2): 166-70.
(16.) Halsey JH Jr. Risks and benefits of shunting in carotid endarterectomy. The International Transcranial Doppler Collaborators. Stroke. 1992;23:1583-7.
(17.) Komoribayashi N, Ogasawara K, Kobayashi M, Saitoh H, Terasaki K, Inoue T, et al. Cerebral hyperperfusion after carotid endarterectomy is associated with preoperative hemodynamic impairment and intraoperative cerebral ischemia. J Cerebral Blood Flow Metab. 2006;26:878-84, http://dx.doi.org/10.1038/sj.jcbfm.9600244
(18.) Holm J, Nilsson V, Waters N, Waters S, Jonsson O. Production of free radicals measured by spin trapping during operations for stenosis of the carotid artery. Eur J Surg. 2001;167:4-9, http://dx.doi.org/10.1080/110241501750069738
(19.) Karibe H, Chen SF, Zarow GJ, Gafni J, Graham SH, Chan PH, et al. Mild intraischemic hypothermia suppresses consumption of endogenous antioxidants after temporal focal ischemia in rats. Brain Res. 1994;649:12-8.
(20.) Brouns R, De Vil B, Cras P, De Surgeloose D, Marien P, De Deyn PP. Neurobiochemical markers of brain damage in cerebrospinal fluid of acute ischemic stroke patients. Clin Chem. 2010;56(3):451-8, http://dx.doi.org/10.1373/clinchem.2009.134122
SERUMSKA RAZINA ZA NEURON SPECIFICNE ENOLAZE KAO BILJEG ISHEMIJSKO-REPERFUZIJSKOG OSTECENJA U BOLESNIKA PODVRGNUTIH KAROTIDNOJ ENDARTEREKTOMIJI
M. Ilzecki, J. Ilzecka, S. Przywara, P. Terlecki, A. Grabarska, A. Stepulak i T. Zubilewicz
Kirurska intervencija je ucinkovita metoda sprjecavanja ishemijskog mozdanog udara u bolesnika s aterosklerotskom stenozom ekstrakranijskog dijela unutarnje karotidne arterije. Medutim, ovaj kirurski zahvat moze uzrokovati ostecenje mozdanog krvozilja. Cilj ovoga istrazivanja bio je ispitati posljedicno ishemijsko-reperfuzijsko ostecenje mozga mjerenjem za neuron specificne enolaze (neuron-specific enolase, NSE) kao specificnog mozdanog biljega u serumu bolesnika podvrgnutih endarterektomiji unutarnje karotide (internal carotid endarterectomy, CEA). Istrazivanje je obuhvatilo 25 bolesnika podvrgnutih CEA zbog stenoze unutarnje karotidne arterije. Uzorci krvi uzeti su u svakog bolesnika tri puta: unutar 24 h prije operacije, 12 h nakon operacije i 48 h nakon operacije. Serumske razine NSE mjerene su komercijalnim testom ELISA. Rezultati su pokazali da je serumska razina NSE bila statisticki znacajno povisena 48 h nakon CEA u usporedbi s razinom izmjerenom 12 h nakon operacije, kao i u usporedbi s razinom prije operacije (p<0,05). Razlika u serumskoj razini NSE prije operacije i 12 h nakon CEA nije bila statisticki znacajna (p>0,05). Podaci dobiveni u ovom istrazivanju pokazuju da CEA utjece na razinu NSE u serumu kod bolesnika sa znacajnom stenozom unutarnje karotidne arterije. Stoga bi serumska razina NSE mogla posluziti kao biokemijski biljeg ishemijsko-reperfuzijskog ostecenja mozga nakon CEA.
Kljucne rijeci: Endarterektomija karotide; Ishemijski mozdani udar; Enolaza specificna za neuron
Marek Ilzecki (1), Joanna Ilzecka (2), Stanislaw Przywara (1), Piotr Terlecki (1), Aneta Grabarska (3), Andrzej Stepulak (3) and Tomasz Zubilewicz (1)
(1) Chair and Department of Vascular Surgery and Angiology, (2) Independent Neurological Rehabilitation Unit, (3) Chair and Department of Biochemistry and Molecular Biology, Medical University of Lublin, Lublin, Poland
Correspondence to: Marek Ilzecki, MD, PhD, Chair and Department of Vascular Surgery and Angiology, Medical University of Lublin, Staszica 16, 20-081 Lublin, Poland
Received November 16, 2015, accepted July 21, 2016
Table 1. Serum neuron-specific enolase (NSE) levels and comparative analysis NSE level (ng/mL) N Mean SD Median Min Max p NSE 1 25 1.34 0.38 1.29 0.43 2.14 <0.001 (*) NSE 2 25 1.59 0.43 1.53 0.98 2.52 NSE 3 25 2.00 0.95 1.82 0.31 4.09 ANOVA test; (*) statistically significant Table 2. Comparative analysis of neuron--specific enolase (NSE) levels in patient sera Difference Significance NSE 1--NSE 2 p=0.2764 NSE 2--NSE 3 p=0.0338 (*) NSE 1--NSE 3 p=0.0005 (*) Post hoc Tukey HSD test; (*) statistically significant Table 3. Correlation of serum neuron--specific enolase (NSE) levels with blood flow velocity in internal carotid artery Correlation r Significance NSE 1 & blood flow 1 -0.11 p=0.6069 NSE 2 & blood flow 1 -0.15 p=0.4646 NSE 3 & blood flow 1 -0.12 p=0.5624 NSE 1 & blood flow 2 0.11 p=0.5941 NSE 2 & blood flow 2 0.16 p=0.4422 NSE 3 & blood flow 2 0.28 p=0.1693
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Original Scientific Paper|
|Author:||Ilzecki, Marek; Ilzecka, Joanna; Przywara, Stanislaw; Terlecki, Piotr; Grabarska, Aneta; Stepulak, A|
|Publication:||Acta Clinica Croatica|
|Date:||Dec 1, 2016|
|Previous Article:||Personality changes following brain artery aneurysm surgery.|
|Next Article:||Use of alternative and complementary medicine in patients with malignant diseases in high-volume cancer center and future aspects.|